Obesity and Healthy Thinking Study

This study is being done to learn if Egrifta may improve brain function in HIV positive people with abdominal obesity, which increases the risk for impaired thinking. Call Rod Hagan at 760.507.3321 or email:rhagan@borregomedical.org  

For more information Click on the PDF.


REPRIEVE Randomized Trial to Prevent Vascular Events in HIV

People living with HIV are 50–100% more likely to develop heart disease (including heart attack and stroke) than people without HIV.

REPRIEVE is a clinical research trial exploring long-term prevention of heart disease among people living with HIV.

Call: 1-877-29-HEART www.reprievetrial.org Leah Lane

760-834-7949 or email: llane@emc.org

For more information Click on the PDF.


Current Clinical Trials

Clinicians at Eisenhower Medical Center continue to take part in groundbreaking research, including: interventional cardiology, orthopedics, novel biotherapies in oncology, targeted therapies base on molecular profile of cancer, early detection of cancer via specialized imaging, drugs aimed at improving survival of HIV patients, and use of integrative therapies to reduce side effects related to cancer treatment.


Investigational HIV Treatment

Recruiting participants who have a current viral load >400 copies :  Investigating PRO 140 subcutaneous injection once weekly combine with OBT in treatment experienced patients.

For more information visit: www.palmtreeclinical.com

For more information Click on the PDF.


idiopathic pulmonary fibrosis (IPF)

The GALACTIC-1 study will research a potential study drug that could offer benefit to patients with IPF. Thank you for considering participation in this trial.

For more information visit: www.palmtreeclinical.com

  • Twitter
  • YouTube - Black Circle
  • Facebook - Black Circle

A 501(c)(3) Non-Profit CorporationEIN: 47-3892886

© 2017CVCRI, Inc. d/b/a HIV & Aging Research Project-Palm Springs

1775 E. Palm Canyon Dr, Suite 110-349, Palm Springs, CA 92264